Ameliorating effects of hyperbaric oxygenation on experimental allergic encephalomyelitis

Area of Science:

• Neuroscience
• Immunology
• Hyperbaric Medicine

Background:

• Experimental allergic encephalomyelitis (EAE) is an animal model for multiple sclerosis.
• EAE is characterized by inflammation and demyelination in the central nervous system.
• Hyperbaric oxygenation (OHP) involves breathing pure oxygen in a pressurized environment.

Purpose of the Study:

• To investigate the effects of OHP on survival and quality of survival in guinea pigs with EAE.
• To determine if OHP can ameliorate the clinical manifestations of EAE.

Main Methods:

• EAE was induced in Hartley and Strain 13 guinea pigs using spinal cord homogenate and complete Freund's adjuvant.
• Animals were divided into control and OHP treatment groups.
• OHP treatment involved exposure to 100% oxygen at various pressures and durations post-inoculation.
• Clinical signs of EAE and mean survival times were quantitatively assessed.

Main Results:

• OHP treatment significantly increased mean survival times in both Hartley and Strain 13 guinea pigs compared to controls (p<0.050 and p<0.001, respectively).
• The onset of EAE clinical signs was delayed by 4-6 days in OHP-treated animals compared to controls.
• OHP therapy demonstrated a protective effect against EAE progression.

Conclusions:

• Hyperbaric oxygenation therapy shows promise as a treatment for experimental allergic encephalomyelitis.
• OHP may be a viable therapeutic strategy for neuroinflammatory conditions like EAE.
• Further research is warranted to explore the mechanisms underlying OHP's beneficial effects in EAE.